Natixis Advisors LLC Has $9.46 Million Stake in Azenta, Inc. (NASDAQ:AZTA)

Key Points

• Natixis Advisors LLC reduced its stake in Azenta, Inc. by 27.0%, selling 101,113 shares and owning approximately 0.60% of the company worth $9,457,000 after the sale.
• Several other institutional investors have also modified their holdings, with notable increases including a 195.3% rise from Russell Investments Group Ltd. and a 90.6% increase from SG Americas Securities LLC in the first quarter.
• Azenta's stock has experienced volatility, reaching a 12-month low of $23.91 and a high of $60.60, with a current trading price of $26.90.

Natixis Advisors LLC decreased its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 27.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 273,000 shares of the company's stock after selling 101,113 shares during the quarter. Natixis Advisors LLC owned about 0.60% of Azenta worth $9,457,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the company. Premier Fund Managers Ltd raised its stake in Azenta by 20.2% in the 1st quarter. Premier Fund Managers Ltd now owns 16,699 shares of the company's stock valued at $578,000 after purchasing an additional 2,807 shares during the last quarter. Federated Hermes Inc. grew its holdings in shares of Azenta by 1.2% during the 1st quarter. Federated Hermes Inc. now owns 771,091 shares of the company's stock worth $26,711,000 after purchasing an additional 8,902 shares during the period. Bryce Point Capital LLC lifted its position in Azenta by 74.6% during the 1st quarter. Bryce Point Capital LLC now owns 13,418 shares of the company's stock worth $465,000 after acquiring an additional 5,731 shares in the last quarter. LPL Financial LLC lifted its position in Azenta by 5.9% during the 1st quarter. LPL Financial LLC now owns 53,328 shares of the company's stock worth $1,683,000 after acquiring an additional 2,986 shares in the last quarter. Finally, Wakefield Asset Management LLLP acquired a new position in shares of Azenta in the 1st quarter valued at approximately $861,000. Institutional investors and hedge funds own 99.08% of the company's stock.

Azenta Price Performance

Shares of AZTA traded down $0.38 on Friday, reaching $28.76. 432,970 shares of the stock traded hands, compared to its average volume of 777,771. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -11.87 and a beta of 1.59. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $56.28. The stock's 50-day moving average price is $31.07 and its 200-day moving average price is $34.65.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.13 by $0.06. The business had revenue of $143.94 million for the quarter, compared to analyst estimates of $149.64 million. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%. Azenta's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.14 EPS. As a group, equities research analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Stephens assumed coverage on Azenta in a research report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 target price on the stock. Evercore ISI set a $33.00 target price on Azenta and gave the stock an "in-line" rating in a research report on Tuesday. Needham & Company LLC decreased their price target on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Finally, Raymond James Financial raised Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 target price on the stock in a report on Wednesday. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $35.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.